Related Experiment Videos
Pseudotumor cerebri in systemic lupus erythematosus
Seminars in Arthritis and Rheumatism
|October 1, 1995
Summary
The association between pseudotumor cerebri (PC) and systemic lupus erythematosus (SLE) is likely not coincidental. A hypercoagulable state, possibly due to microthrombi, may contribute to PC development in SLE patients.
Area of Science:
- Neurology
- Rheumatology
- Pathology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Pseudotumor cerebri (PC), also known as idiopathic intracranial hypertension, is characterized by increased intracranial pressure without a clear cause.
- The potential association between SLE and PC requires further investigation to understand underlying mechanisms.
Observation:
- A review of 13 articles and analysis of 21 patients revealed coexisting PC and SLE.
- Patients with both conditions often presented with severe SLE, including significant renal involvement (79%) and proteinuria (47%).
- A hypercoagulable state, indicated by thromboembolic events or high anti-cardiolipin antibody titers, was observed in 58% of these patients.
Findings:
- The co-occurrence of PC and SLE suggests a link beyond chance.
- The high prevalence of hypercoagulability in patients with both SLE and PC points to a potential pathogenic role.
- Microthromboembolic events are hypothesized to contribute to the development of PC in the context of SLE.
Implications:
- This association highlights the importance of considering PC in SLE patients, especially those with severe disease or hypercoagulable states.
- Understanding the role of hypercoagulability may lead to novel therapeutic strategies for preventing or managing PC in SLE.
- Further research into the specific mechanisms linking autoimmune disease, hypercoagulability, and intracranial hypertension is warranted.